Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

Abstract: Build on the experience from national trials for paediatric Hodgkin's lymphoma (PHL) experts from 12 EU countries decided on a common protocol to individualise PHL treatment.

The general objective of this proposal is to ensure a high-quality teatment for all affected patients from paediatric Hodgkin's lymphoma independent of their social or geographical origin by establishing a shared case management and expert system using a medical image and communication network. Aim of the high-quality treatment planning algorithm is to achieve high rates for event-free survival with the least necessary treatment toxicity in every child.

Beteiligte MUG-Organisationseinheiten: Klinische Abteilung für Nuklearmedizin

Projektpartner: Centrum Onkologii IM F. Lukaszczyka w Bydgoszczy Co Bydgoszcz, Polen; Fakultni Nemocnice v Motole, Tschechische Republik; Fundacion Vasca de Innovacion e Investigacion Sanitarias-BIOEF, Spanien; Hospital Universitario La Paz, Spanien; Jagiellonian University Medical College, Polen; Karolinska Universitetssjukhuset , Schweden; Martin-Luther Universität Halle-Wittenberg, Deutschland; Medizinische Universität Leipzig, Deutschland; NHS Lothian Health Board, Großbritannien; Onkologicky Ustav sv. Alzbety, Slowakei; Our Lady`s Children Hospital, Irland; Rigshospitalet University of Copenhagen, Dänemark; Rikshoapitalet-Radiumhospitalet HF, Norwegen; Universite Pierre et Marie Curie, Frankreich; Uniwersyteki Szpital Dzieciecy w Krakowie, Polen